First Minister opens new £44 million facility at GlaxoSmithKline’s Montrose site

© PAThe new facility produces ingredients for vaccines for illnesses including tetanus, pneumonia and whooping cough.
The new facility produces ingredients for vaccines for illnesses including tetanus, pneumonia and whooping cough.